The application of the vaccine against the SARS-CoV-2 virus in minors is difficult for security reasons – Bulletins Dependencies

Guanajuato, Guanajuato, February 23, 2022.- The application of the vaccine against the SARS-CoV-2 virus. in children between 5 and 11 years of age it is difficult in the state and in the country for security reasons, as reported by Dr. Daniel Díaz Martínez, Secretary of Health of the state of Guanajuato.

He reported that vaccination in minors of this age range is desirable as it is happening in other parts of the world, but in Mexico and in the state it is very difficult to achieve at the moment, because an application of only the third part of the Pfizer doses that are being applied to adults.

He clarified that despite the protection that many parents have processed, while in Mexico there is no biological insurance for minors between the ages of 5 and 11, it will not be applied.

All this information has been shared with the legislators who, with good will, have guided the parents for the process of collective amparos and there are no false expectations.

While medical evaluations have been carried out on each covered child, so that they are prepared in case the vaccine is available.

The health minister asserted that Guanajuato, like the rest of the entities, advocates with the Federation to obtain a safe vaccine for this sector of the population that, with the economic reactivation, has had to increase their mobility with the return to classes.

In the meantime, he pointed out that a false expectation of application should not be created because this will not happen soon.

Read more:  One after another, Geshev and Petkov talk about judicial reform in Brussels

He recalled that there is still a global shortage due to the creation of biologicals against COVID-19 and this probably contributes to the fact that at the moment there is no safe Pfizer-brand biological for children between 5 and 11 years of age.

Related News

Leave a Reply

Your email address will not be published. Required fields are marked *

This site uses Akismet to reduce spam. Learn how your comment data is processed.

Recent News

Editor's Pick